Drug could change the standard treatment during procedures to clear blocked arteriesSeptember 11, 2006A study led by a University of Kentucky researcher being published in the country's leading medical journal could one day change the standard treatment for preventing blood clots during procedures to open up blocked arteries feeding the heart. Dr. Steven Steinhubl, co-chairman and senior author of a study appearing in the current issue of the New England Journal of Medicine, said the drug used in the study, enoxaparin, has the potential to become a standard treatment in stent and angioplasty procedures, but more research is necessary to come to a definitive conclusion. The current standard of care is to give patients unfractionated heparin. Steinhubl, an interventional cardiologist and researcher at UK's Linda and Jack Gill Heart Institute, said that while elective stent and angioplasty procedures to clear blocked arteries are generally safe, a small percentage of patients will experience significant bleeding due to the procedure that can increase the cost and duration of the hospital stay and, in rare instances, even cause death. In the study, researchers examined enoxaparin to determine if it is a safe and effective anti-clotting drug, carrying less risk for bleeding following the procedure than unfractionated heparin. The study found that major bleeding was cut by more than half in patients receiving enoxaparin. It also showed that doctors were much more likely to achieve the targeted level of blood thinning for their patients with enoxaparin compared with unfractionated heparin. "Bleeding following a stent placement or angioplasty is an event that is not only dangerous for patients, but also carries a financial burden for the health care industry as a whole," Steinhubl said. "Millions of these procedures are successfully performed at hospitals across the United States each year. It is important that we make what has become a relatively safe procedure even safer by finding a drug that will effectively prevent blood clots and not put patients at risk for unnecessary bleeding. This study, which was designed to test the safety of enoxaparin, is one of the first steps we as cardiologists are taking to reach that goal." University of Kentucky |
|||||||||||||||
| Related Blocked Arteries Current Events and Blocked Arteries News Articles Your Own Stem Cells Can Treat Heart Disease The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells. Higher carotid arterial stenting rates associated with poorer clinical outcomes Among eligible Medicare beneficiaries, increased use of carotid arterial stenting (CAS) procedures to treat carotid stenosis-the narrowing of the carotid artery-is associated with higher rates of mortality and adverse clinical outcomes, including heart attack and stroke, according to researchers from the University of Pennsylvania School of Medicine. Two treatment innovations improve heart function after heart attack Supersaturated oxygen (SSO2) administered during catheter-based treatments for heart attack can significantly reduce heart muscle damage, according to a new study reported in Circulation: Cardiovascular Interventions, a journal of the American Heart Association. Oxygen-saturated blood reduces levels of damaged heart tissue following a heart attack Results of a clinical trial published today in Circulation: Cardiovascular Interventions demonstrate that an infusion of blood that is "supersaturated" with oxygen (SS02) can reduce the amount of damaged heart muscle immediately following a life-threatening heart attack. New drug may reduce heart attack damage A new drug that targets a master disease-causing gene can dramatically reduce heart muscle damage after a heart attack and may lead to significantly improved patient outcomes, UNSW researchers have shown. Death rates same for diabetes and heart disease patients receiving drug therapy or surgery There is no difference in mortality among patients with type 2 diabetes and stable heart disease who received prompt bypass surgery or angioplasty compared to drug therapy alone, according to a landmark study focused exclusively on patients with both conditions. Women with chest pain less likely then men to get proper treatment from paramedics Women with chest pain are less likely than male patients to receive recommended, proven therapies while en route to the hospital. Arrythmia associated with heart attacks linked to higher risk of death Heart attack patients who develop serious arrhythmia in connection with procedures to open blocked arteries face a significantly higher risk of death for several months after the procedure, when compared to similar patients who do not develop such complications, according to new research from Duke University Medical Center. Study proves that practice makes perfect in PCI for heart attack When it comes to treating heart attacks, experience matters. New research shows that patients have a much better chance of survival when both their hospital and their physician have a strong track record in treating heart attack with angioplasty and stenting. 'Smart scaffolds' may help heal broken hearts Imagine new treatments for heart disease or muscle loss that direct the body to repair damaged tissue rather than helping it cope with a weakened condition. More Blocked Arteries Current Events and Blocked Arteries News Articles |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||